273 related articles for article (PubMed ID: 23590558)
1. An investigation of prescription and over-the-counter supply of ophthalmic chloramphenicol in Wales in the 5 years following reclassification.
Du HC; John DN; Walker R
Int J Pharm Pract; 2014 Feb; 22(1):20-7. PubMed ID: 23590558
[TBL] [Abstract][Full Text] [Related]
2. Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability.
Walker R; Hinchliffe A
Int J Pharm Pract; 2010 Oct; 18(5):269-74. PubMed ID: 20840682
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia.
Alkhatib L; Parsons R; Czarniak P; Sunderland VB
Int J Pharm Pract; 2015 Apr; 23(2):111-20. PubMed ID: 24841453
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
5. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
[TBL] [Abstract][Full Text] [Related]
6. Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018.
Tse WC; Sanfilippo P; Lam T; Dietze P; Nielsen S
Med J Aust; 2020 Apr; 212(7):314-320. PubMed ID: 32124984
[TBL] [Abstract][Full Text] [Related]
7. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
Dhippayom T; Walker R
Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
[TBL] [Abstract][Full Text] [Related]
8. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
[TBL] [Abstract][Full Text] [Related]
9. Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic.
Karlsson P; Nakitanda AO; Löfling L; Cesta CE
PLoS One; 2021; 16(8):e0253944. PubMed ID: 34388166
[TBL] [Abstract][Full Text] [Related]
10. Utilization of triptans in Sweden; analyses of over the counter and prescription sales.
von Euler M; Keshani S; Baatz K; Wettermark B
Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1288-93. PubMed ID: 25044442
[TBL] [Abstract][Full Text] [Related]
11. [Functional characteristics of pharmacy services related to home care in a certain suburban area].
Onda M; Kono K; Watanabe T; Watanabe M; Dote T; Usuda K; Shirai Y; Mima C
Nihon Koshu Eisei Zasshi; 2001 Jul; 48(7):534-42. PubMed ID: 11524828
[TBL] [Abstract][Full Text] [Related]
12. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study.
Hedenrud T; Andersson Sundell K; Martinsson J; Håkonsen H
Int J Pharm Pract; 2019 Feb; 27(1):17-24. PubMed ID: 29687513
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing purchase of and counselling about prescription and OTC medicines at community pharmacies in Tallinn, Estonia.
Villako P; Volmer D; Raal A
Acta Pol Pharm; 2012; 69(2):335-40. PubMed ID: 22568049
[TBL] [Abstract][Full Text] [Related]
14. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
[TBL] [Abstract][Full Text] [Related]
15. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.
Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L
Eur J Clin Pharmacol; 2016 Apr; 72(4):469-94. PubMed ID: 26690771
[TBL] [Abstract][Full Text] [Related]
16. Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries.
Wirtz VJ; Herrera-Patino JJ; Santa-Ana-Tellez Y; Dreser A; Elseviers M; Vander Stichele RH
Trop Med Int Health; 2013 Jun; 18(6):665-73. PubMed ID: 23551290
[TBL] [Abstract][Full Text] [Related]
17. OTC market - comparing Czech Republic and Greece.
Macešková B; Tsadaris MP; Machlis M
Ceska Slov Farm; 2019; 68(2):78-85. PubMed ID: 31331177
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting.
Watson MC; Bond CM; Grimshaw J; Johnston M
Qual Saf Health Care; 2006 Feb; 15(1):53-7. PubMed ID: 16456211
[TBL] [Abstract][Full Text] [Related]
19. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
[TBL] [Abstract][Full Text] [Related]
20. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market.
Håkonsen H; Sundell KA; Martinsson J; Hedenrud T
Health Policy; 2016 Mar; 120(3):327-33. PubMed ID: 26861972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
